October 2024

Company Debuts Premium Banked Product Dynasty Luna™ and For-Sale Stepper Cabinet Player Classic Spin™ with Mechanical Wheel Robust Game Roadmaps Across All Categories Everi Holdings Inc. (NYSE: EVRI) (“Everi” or “the Company”), a premier provider of land-based and digital casino gaming content and products, financial technology, player loyalty solutions, and bingo, will highlight its commitment…

Liberty Star Minerals Announces Equity Financing Agreement Exploration Work on Red Rock Canyon Gold Project TUCSON, AZ, Oct. 02, 2024 (GLOBE NEWSWIRE) — Liberty Star Minerals (” Liberty Star ” or the ” Company “) ( OTCMarkets: LBSR ) is pleased to announce that on September 25, 2024 we entered into an “Equity Financing Agreement”…

LLAP Investors: Lead the Way in the Terran Orbital Corporation Securities Fraud Lawsuit with The Schall Law Firm Description: LOS ANGELES , Oct. 2, 2024 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Terran Orbital Corporation (“Terran Orbital” or “the Company”) (NYSE: LLAP)…

Lesaka Technologies Acquires Adumo RF Expanding Horizons: Lesaka Technologies’ Latest Acquisition On October 2, 2024, Lesaka Technologies, Inc. announced the successful completion of its acquisition of Adumo RF (Pty) Ltd. This strategic move was finalized through the issuance of 17,279,803 shares of Lesaka’s common stock and a cash payment of ZAR 232.2 million ($13.4 million),…

Welcome to the Cannabis Success Story! A Remarkable 50% Increase in Revenue for IM Cannabis Corp. October 2, 2024 Hey there, fellow cannabis enthusiasts! Have you heard the exciting news? IM Cannabis Corp. is on a winning streak with their German subsidiary, Adjupharm GmbH, reporting a phenomenal 50% increase in revenue for the third quarter…

ATH434 Shows Promise as a Disease-Modifying Therapy for MSA ATH434-202 Phase 2 Interim Data Demonstrate Stabilization of Clinical Symptoms MELBOURNE, Australia and SAN FRANCISCO, Oct. 02, 2024 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that multiple oral and poster…

Record Quarterly and September ADV for CME Group in Q3 2024 CME Group Breaks Records with 28.3 Million Contracts in Q3 CME Group, the world’s leading derivatives marketplace, has reported record-breaking numbers for the third quarter of 2024. With an average daily volume (ADV) of 28.3 million contracts, the company saw a hefty 27% increase…